Evidence map›Paper›PMID 19261742›Full record

ReviewAmerican journal of physiology. Renal physiology2009

Aldosterone in the brain.

Joel C Geerling, Arthur D Loewy

Open access · greenAbstract readReview
In one paragraph

Review in American journal of physiology. Renal physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 182 citations in OpenAlex.

  1. Trial
  2. Trial
  3. A modifiable driver of dementia: cognitive impairment in primary aldosteronism.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Review
  4. Article
  5. Review
  6. Non-Hypertensive Effects of Aldosterone.International journal of molecular sciences · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Treatment withNutrients · 2024
    Article
  11. Review
  12. Article
  13. Neurosteroid Receptor Modulators for Treating Traumatic Brain Injury.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Joel C GeerlingDept. of Anatomy and Neurobiology-Box 8108, Washington Univ. School of Medicine, 660 S. Euclid Ave., St. Louis, MO 63110, USA. joel.geerling@gmail.com
Arthur D Loewy
Washington University in St. Louis · US

Funding

CNS AUTONOMIC PATHWAYS: CENTRAL CARDIOVASCULAR CONTROLR01HL025449 · NHLBI · WASHINGTON UNIVERSITY · PI LOEWY, ARTHUR D · 1985 to 2012
$5.4M
CNS AUTONOMIC PATHWAYS: CENTRAL CARDIOVASCULAR CONTROLR37HL025449 · NHLBI · WASHINGTON UNIVERSITY · PI LOEWY, ARTHUR D · 1990 to 1999
–
NHLBI NIH HHS HL-25449NHLBI NIH HHS R01 HL025449
6 · The paper itself

Abstract

Pharmacological and physiological phenomena suggest that cells somewhere inside the central nervous system are responsive to aldosterone. Here, we present the fundamental physiological limitations for aldosterone action in the brain, including its limited blood-brain barrier penetration and its substantial competition from glucocorticoids. Recently, a small group of neurons with unusual sensitivity to circulating aldosterone were identified in the nucleus of the solitary tract. We review the discovery and characterization of these neurons, which express the enzyme 11beta-hydroxysteroid dehydrogenase type 2, and consider alternative proposals regarding sites and mechanisms for mineralocorticoid action within the brain.

Indexed as

11-beta-Hydroxysteroid Dehydrogenase Type 2AldosteroneAnimalsBlood-Brain BarrierBrainGlucocorticoidsHumansMineralocorticoidsNeuronsSodiumSolitary Nucleus11-beta-Hydroxysteroid Dehydrogenase Type 2AldosteroneGlucocorticoidsMineralocorticoidsSodium

Identifiers

PMID19261742
PMCPMC2739715
OpenAlexW2013521729

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.